ENGLISH
|
HINDI
APPS
iPhone
|
iPad
|
BlackBerry
|
Android
Nokia
Windows
Network18
Quotes
Quotes
NAVs
News
Messages
People
Notices
Videos
All
FEEDBACK
Facebook
Follow @moneycontrolcom on Twitter
CNBC TV 18
moneycontrol
News
Markets
Mutual Funds
IPO
Commodities
Wealth
Portfolio
Messages
My TV
Tax
Fixed Income
Property
SME
CNBC-TV18
Home
Business
General News
Market Trends
Stocks
Fund News
Personal Finance
Corporate Strategy
Lifestyle
Politics
Legal
Master Your Money
Share
>
Share
Tweet
Share on Tumblr
Dhananjay Patankar
News »
latest
by relevance
IBPL plans manufacturing facility for Monoclonal Antibodies
Jan 16, 2009 at 15:09
Intas Biopharmaceuticals Limited, Indias leading biotechnology company, signed a Memorandum of Understanding (MoU) with Government of Gujarat for setting up a separate manufacturing facility for Monoclonal Antibodies (MAbs), a recombinant mammalian platform product.
Intas Biopharma & Kwizda complete clinical trial of Neukine
Apr 09, 2008 at 15:35
Intas Biopharmaceuticals Limited (IBPL) and European pharmaceutical major Kwizda Pharma GmbH has jointly completed Phase I clinical trial study of Neukine, biosimilar form of recombinant GCSF
IBPL signs R&D agreement with Virionics
May 31, 2007 at 12:36
IBPL signs R&D agreement with US-based Virionics to develop therapeutic vaccine for Cervical Cancer
IBPL plans manufacturing facility for Monoclonal Antibodies
Jan 16, 2009 at 15:09
Intas Biopharmaceuticals Limited, Indias leading biotechnology company, signed a Memorandum of Understanding (MoU) with Government of Gujarat for setting up a separate manufacturing facility for Monoclonal Antibodies (MAbs), a recombinant mammalian platform product.
Intas Biopharma & Kwizda complete clinical trial of Neukine
Apr 09, 2008 at 15:35
Intas Biopharmaceuticals Limited (IBPL) and European pharmaceutical major Kwizda Pharma GmbH has jointly completed Phase I clinical trial study of Neukine, biosimilar form of recombinant GCSF
IBPL signs R&D agreement with Virionics
May 31, 2007 at 12:36
IBPL signs R&D agreement with US-based Virionics to develop therapeutic vaccine for Cervical Cancer
Photos »
/
Follow moneycontrol.com
Facebook
Twitter
Google Plus
RSS
Wap SMS
SMS
Alert
iPad
iPhone
Blackberry
OVI
Android
Window
/ 
/
/